News & Articles

A qualitative test for the detection of nucleic acid from SARS-CoV-2

Study suggests that type I IFN deficiency in the blood could help define a high-risk population

The COVID-19 vaccine trial is part of a global development program that will uncover the safety and immunogenicity of four mRNA vaccine candidates.

Test deployed on Quanterix' Simoa platform promises 1,000-fold sensitivity improvement

Collaboration with WuXi Diagnostics and Mayo Clinic on serology test will complement Thermo Fisher's widely adopted TaqPath COVID-19 molecular diagnostic test

The digital tool could help simplify the screening, diagnosis and monitoring of patients with respiratory compromise in the current COVID-19 pandemic

A research team at the University of Cambridge has designed a ventilator for treating COVID-19 patients that can be quickly and cheaply manufactured

Clinical laboratories certified to perform high complexity tests under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this ELISA

Register today to reserve a place at the Summit - it opens at 13:00 (BST) / 14:00 (CEST) / 08:00 (EDT) / 05:00 (PDT) on Monday, May 11

The serology test promises 100% sensitivity and can help assess patients' immune response to the virus

The antibody test, which has a potential time to result of 14 minutes, will join the rest of the company's diagnostic portfolio

The company aims to provide solutions for the pandemic through close collaboration with scientists and providing cutting-edge laboratory equipment

The test will be available for qualified laboratories across the European Union by the end of May

Watch this on-demand webinar to understand how better research diagnostic methods can lead to improved treatment of congenital metabolopathies

Explore a compilation of some of the most innovative technology news relating to the novel coronavirus and the COVID-19 disease

The detection of these antibodies could help indicate if a person has gained immunity against the virus and inform treatment decisions

The only FDA-approved test that measures G6PD provides key insight to inform drug therapy options

The FreeStyle Libre 14 day system can be used by frontline healthcare workers tackling the coronavirus

The RAPIDPoint 500e blood gas analyzer aims to meet the unprecedented demand for blood gas testing in coronavirus patients

The Abbott ID NOW™ COVID-19 test aims to bring rapid testing to the front lines of the global pandemic

The collaboration aims to develop novel, targeted treatments to address significant unmet needs

Scientists say early data, generated with new NGS research panel from Thermo Fisher Scientific, suggest coronavirus is genetically stable, and could increase the effectiveness of vaccines in development

AI-driven proteogenomic analysis company applies single-cell analysis expertise to develop treatments for COVID-19

The test will be used on the m2000 RealTime system that is currently available in hospitals and molecular laboratories in the U.S.

The Standard is said to contain synthetic COVID-19 RNA transcripts and human genomic DNA